Translational research and entrepreneurship seminar set for July 14 at IUPUI to feature founder/director of Stanford's SPARK program

Dr. Daria Mochly-Rosen, who founded and directs Stanford University’s SPARK translational research and commercialization program, will discuss “Translational Research in Academia – Correcting Abnormal Mitochondrial Dynamics in Neurodegenerative Diseases” at a Tuesday, July 14, seminar at Indiana University Purdue University Indianapolis.

The seminar is scheduled for 11 a.m. to noon in Room 1110 of the Health Information and Translational Sciences building (also known as HITS or HS on IUPUI campus maps) at 410 W. 10th St. in Indianapolis.

In 2006, Mochly-Rosen founded SPARK — an initiative with similarities to the Spin Up program launched by the Indiana University Research and Technology Corp. in 2011 — as a hands-on training program aimed at helping Stanford scientists take promising discoveries from the laboratory to pharmaceutical companies that could make them available to the general public. She also founded KAI Pharmaceuticals, a company focused on treatments of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, which Amgen later acquired in 2012.

For more information on the seminar, click here: